Icon
+91 94997 68112
Login Register

DORYX MPC - (60,120 mg; Tablet, Delayed Release)

DOXYCYCLINE HYCLATE Mayne Pharma
60,120 mg; Tablet, Delayed Release
Less Than $1000 mn
Less Than 5
Less Than 5
Less Than 5
 None
Less Than 5
 None
Indicated for treatment of the following respiratory tract infections: Respiratory tract infections caused by Mycoplasma pneumoniae. susceptibility to the drug: Respiratory tract infections caused by Haemophilus influenzae.
Yes
***** ******** ***** ********* **** ** ************* ** ******* (*** **, ****), ******* (*** **, ****), ******* (*** **, ****) - ** ******* *** *** **** **** **-****** **** ******** ** *** ****. ***** ***** ** ** ***. ***** *** *** **** **** ** ** ***** *** ** ****** ******* *.*. ******* (*** **, ****) *** ******* (*** *, ****). '*** *** ********* *** ***** *** **** **** *** *** ******** ** ******. '*** **** ******* ** ********** ******* *** *** **** ********* ** ***. ***** ***** **** *** ** **** ** ****** *** ******* ****** ****** ** '*** ****** *.*. *** *, ****.
DORYX MPC Patent 1 Patent 2 Patent 3 Patent 4 Patent 5
**** ******* ******* ******* ******* *******
***** ******* ******* ******* ******* *******
******** ****** ******* ******* ******* ******* *******
Company FTF Status / 180 days exclusivity 30-Months stay Current Litigation Status Current Approval Status Likelihood of launch
**** *** \ ** *** **, **** ******* ** ************ ****** **** ********
***** *** \ ** *** **, **** ******* ******** *** ****** *******
******** ****** ** \ ** **** **, **** ******* **** ****** **** ********
  1. *** *, **** : ***** ******** ***** ********* **** ** ************* ** ******* (*** **, ****), ******* (*** **, ****), ******* (*** **, ****) - ** *******
  2. *** **, **** : ***** **** ***** *** **** ** ** ** ********.
  3. *** **, **** : **** *** ********* ******** *** ******* ***** ***. ********* **** ** ******** *** *** **** ***********. *****://***.**********.***.***/**********_****/*********/****/******************.***
  4. *** **, **** : ***** ******* **** ****, ********* ** ********** **** *** ****** ******* ***** *** ** ***** **, **** ** **
  5. *** **, **** : ***** ******* **** *****, ***** *** ***** ** ********** *** *** *****.
  6. *** **, **** : ***** ***** * **** ******* ******** ** ******* ******* (*** **, ****), ******* (*** **, ****) *** ******* (*** **, ****)
  7. *** **, **** : ********** ********* **** ******** ******, ***** *** ***** ** ********* *** *** *****.

Download ParaIV Report

Download ParaIV Detailed Report

To get detailed report Contact Us

ParaIV Advanced Search






Please contact contact@researchdelta.com to get more details.

Headquarters

Research Delta Advisor, G4,Sani Apartment, Bank of india lane, Ellora park, Vadodara 390023

+91 94997 68112

nimish@researchdelta.com

Products & Services

Para IV GenUS Pharmalysis Consulting Valuation

Quick Links

Home About Career Media Coverage Contact
© Research Delta, All Right Reserved.